Session » Sjögren's Syndrome I: Basic Insights
-
Abstract Number: 1051
Serum Calprotectin As Biomarker of Carotid Atherosclerosis in Patients with Primary Sjögren’s Syndrome
-
Abstract Number: 1052
Identification of Novel Sjogren’s Syndrome Risk Loci in the Regions of TNFAIP3 and PRDM1
-
Abstract Number: 1053
Phosphatidylinositol-3-Kinase Delta Pathway a Novel Therapeutic Target for Sjogren’s Syndrome
-
Abstract Number: 1054
A Potential Role of Type III Interferon in the Glandular Involvement of Sjögren’s Syndrome